Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP271043.RAU1VbdlCCJlXymUspQmaja_i00xzV92Jkl5iXiPXpMmg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP271043.RAU1VbdlCCJlXymUspQmaja_i00xzV92Jkl5iXiPXpMmg130_assertion type Assertion NP271043.RAU1VbdlCCJlXymUspQmaja_i00xzV92Jkl5iXiPXpMmg130_head.
- NP271043.RAU1VbdlCCJlXymUspQmaja_i00xzV92Jkl5iXiPXpMmg130_assertion wasGeneratedBy ECO_0000203 NP271043.RAU1VbdlCCJlXymUspQmaja_i00xzV92Jkl5iXiPXpMmg130_provenance.
- NP271043.RAU1VbdlCCJlXymUspQmaja_i00xzV92Jkl5iXiPXpMmg130_assertion wasDerivedFrom befree-20150227 NP271043.RAU1VbdlCCJlXymUspQmaja_i00xzV92Jkl5iXiPXpMmg130_provenance.
- NP271043.RAU1VbdlCCJlXymUspQmaja_i00xzV92Jkl5iXiPXpMmg130_assertion SIO_000772 22143498 NP271043.RAU1VbdlCCJlXymUspQmaja_i00xzV92Jkl5iXiPXpMmg130_provenance.
- NP271043.RAU1VbdlCCJlXymUspQmaja_i00xzV92Jkl5iXiPXpMmg130_assertion evidence source_evidence_literature NP271043.RAU1VbdlCCJlXymUspQmaja_i00xzV92Jkl5iXiPXpMmg130_provenance.
- NP271043.RAU1VbdlCCJlXymUspQmaja_i00xzV92Jkl5iXiPXpMmg130_assertion description "[BRCA1/2 germ line mutation carriers have a high risk of developing fallopian tube carcinoma (FTC), thought to occur through different early (p53 signatures) and later (dysplasia, intra-epithelial carcinoma) premalignant stages.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP271043.RAU1VbdlCCJlXymUspQmaja_i00xzV92Jkl5iXiPXpMmg130_provenance.